The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer
Identifieur interne : 003C21 ( Pmc/Checkpoint ); précédent : 003C20; suivant : 003C22The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer
Auteurs : Mohamad E. Allaf ; Alan W. Partin ; H. Ballentine CarterSource :
- Reviews in Urology [ 1523-6161 ] ; 2006.
Abstract
Despite advances in noninvasive staging, pelvic lymph node dissection (PLND) remains the most accurate means of detecting lymph node metastases in men with clinically localized prostate cancer. Nomograms exist that can identify patients at low risk for lymphatic metastases according to preoperative information. In general, it seems reasonable to omit PLND in men with a biopsy Gleason sum of 6 or less and a prostate-specific antigen level of 10 ng/mL or less. Ultimately, however, this decision should be made according to physician and patient preference, considering the low contemporary morbidity associated with PLND. When PLND is performed, studies suggest that an extended dissection maximizes the detection rate of nodal involvement. Retrospective data indicate that an extended dissection might play a therapeutic role in a subset of patients with a limited lymph node burden. However, this might be an artifact of stage migration, and prospective studies are needed to evaluate this further.
Url:
PubMed: 17043708
PubMed Central: 1578548
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:1578548Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer</title>
<author><name sortKey="Allaf, Mohamad E" sort="Allaf, Mohamad E" uniqKey="Allaf M" first="Mohamad E" last="Allaf">Mohamad E. Allaf</name>
</author>
<author><name sortKey="Partin, Alan W" sort="Partin, Alan W" uniqKey="Partin A" first="Alan W" last="Partin">Alan W. Partin</name>
</author>
<author><name sortKey="Carter, H Ballentine" sort="Carter, H Ballentine" uniqKey="Carter H" first="H. Ballentine" last="Carter">H. Ballentine Carter</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">17043708</idno>
<idno type="pmc">1578548</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1578548</idno>
<idno type="RBID">PMC:1578548</idno>
<date when="2006">2006</date>
<idno type="wicri:Area/Pmc/Corpus">004875</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004875</idno>
<idno type="wicri:Area/Pmc/Curation">004874</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">004874</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003C21</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003C21</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer</title>
<author><name sortKey="Allaf, Mohamad E" sort="Allaf, Mohamad E" uniqKey="Allaf M" first="Mohamad E" last="Allaf">Mohamad E. Allaf</name>
</author>
<author><name sortKey="Partin, Alan W" sort="Partin, Alan W" uniqKey="Partin A" first="Alan W" last="Partin">Alan W. Partin</name>
</author>
<author><name sortKey="Carter, H Ballentine" sort="Carter, H Ballentine" uniqKey="Carter H" first="H. Ballentine" last="Carter">H. Ballentine Carter</name>
</author>
</analytic>
<series><title level="j">Reviews in Urology</title>
<idno type="ISSN">1523-6161</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Despite advances in noninvasive staging, pelvic lymph node dissection (PLND) remains the most accurate means of detecting lymph node metastases in men with clinically localized prostate cancer. Nomograms exist that can identify patients at low risk for lymphatic metastases according to preoperative information. In general, it seems reasonable to omit PLND in men with a biopsy Gleason sum of 6 or less and a prostate-specific antigen level of 10 ng/mL or less. Ultimately, however, this decision should be made according to physician and patient preference, considering the low contemporary morbidity associated with PLND. When PLND is performed, studies suggest that an extended dissection maximizes the detection rate of nodal involvement. Retrospective data indicate that an extended dissection might play a therapeutic role in a subset of patients with a limited lymph node burden. However, this might be an artifact of stage migration, and prospective studies are needed to evaluate this further.</p>
</div>
</front>
</TEI>
<pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Urol</journal-id>
<journal-id journal-id-type="publisher-id">RIU</journal-id>
<journal-title>Reviews in Urology</journal-title>
<issn pub-type="ppub">1523-6161</issn>
<publisher><publisher-name>MedReviews, LLC</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">17043708</article-id>
<article-id pub-id-type="pmc">1578548</article-id>
<article-id pub-id-type="other">1523-6161-8-3-112</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Diagnostic Review</subject>
</subj-group>
</article-categories>
<title-group><article-title>The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Allaf</surname>
<given-names>Mohamad E</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Partin</surname>
<given-names>Alan W</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Carter</surname>
<given-names>H. Ballentine</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<aff><institution>The James Buchanan Brady Urological Institute, Department of Urology, The Johns Hopkins Medical Institutions</institution>
<addr-line>Baltimore, MD</addr-line>
</aff>
</contrib-group>
<pub-date pub-type="ppub"><season>Summer</season>
<year>2006</year>
</pub-date>
<volume>8</volume>
<issue>3</issue>
<fpage>112</fpage>
<lpage>119</lpage>
<permissions><copyright-statement>© 2006 MedReviews, LLC</copyright-statement>
<copyright-year>2006</copyright-year>
<copyright-holder>MedReviews, LLC</copyright-holder>
</permissions>
<abstract><p>Despite advances in noninvasive staging, pelvic lymph node dissection (PLND) remains the most accurate means of detecting lymph node metastases in men with clinically localized prostate cancer. Nomograms exist that can identify patients at low risk for lymphatic metastases according to preoperative information. In general, it seems reasonable to omit PLND in men with a biopsy Gleason sum of 6 or less and a prostate-specific antigen level of 10 ng/mL or less. Ultimately, however, this decision should be made according to physician and patient preference, considering the low contemporary morbidity associated with PLND. When PLND is performed, studies suggest that an extended dissection maximizes the detection rate of nodal involvement. Retrospective data indicate that an extended dissection might play a therapeutic role in a subset of patients with a limited lymph node burden. However, this might be an artifact of stage migration, and prospective studies are needed to evaluate this further.</p>
</abstract>
<kwd-group><title>Key words</title>
<kwd>Prostate cancer</kwd>
<kwd>Lymphadenectomy</kwd>
<kwd>Clinical staging</kwd>
<kwd>Magnetic resonance imaging</kwd>
<kwd>Radioimmunoscintigraphy</kwd>
<kwd>Nomograms</kwd>
<kwd>Algorithms</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
<affiliations><list></list>
<tree><noCountry><name sortKey="Allaf, Mohamad E" sort="Allaf, Mohamad E" uniqKey="Allaf M" first="Mohamad E" last="Allaf">Mohamad E. Allaf</name>
<name sortKey="Carter, H Ballentine" sort="Carter, H Ballentine" uniqKey="Carter H" first="H. Ballentine" last="Carter">H. Ballentine Carter</name>
<name sortKey="Partin, Alan W" sort="Partin, Alan W" uniqKey="Partin A" first="Alan W" last="Partin">Alan W. Partin</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C21 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 003C21 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:1578548 |texte= The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:17043708" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |